All terms in MESH
| Label | Id | Description |
|---|---|---|
| neopyrrolomycin | C066136 | |
| depsidomycin | C066137 | |
| xanthenone-4-acetic acid | C066138 | |
| nitro-bis(2,4-pentanedionato)(pyridine)cobalt(III) | C066139 | |
| Antibiotics, Antineoplastic | D000903 | [Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.] |
| Antibiotics, Antitubercular | D000904 | [Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic.] |
| Immunoglobulins | D007136 | [Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses.] |
| Antibodies, Fungal | D000908 | [Immunoglobulins produced in a response to FUNGAL ANTIGENS.] |
| Antibodies, Helminth | D000909 | [Immunoglobulins produced in a response to HELMINTH ANTIGENS.] |
| Antibodies, Heterophile | D000910 | [Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.] |
| Antibodies, Monoclonal | D000911 | [Antibodies produced by a single clone of cells.] |
| Antibodies, Neoplasm | D000912 | [Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS.] |
| Antibodies, Protozoan | D000913 | [Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.] |
| Antibodies, Viral | D000914 | [Immunoglobulins produced in response to VIRAL ANTIGENS.] |
| Antibody Affinity | D000915 | [A measure of the binding strength between antibody and a simple hapten or antigen determinant. It depends on the closeness of stereochemical fit between antibody combining sites and antigen determinants, on the size of the area of contact between them, and on the distribution of charged and hydrophobic groups. It includes the concept of "avidity," which refers to the strength of the antigen-antibody bond after formation of reversible complexes.] |
| Antibody Diversity | D000916 | [The phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS.] |
| Genetic Variation | D014644 | [Genotypic differences observed among individuals in a population.] |
| Antibody Formation | D000917 | [The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.] |
| Antibody Specificity | D000918 | [The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.] |
| Antibody-Coated Bacteria Test, Urinary | D000919 | [Fluorescent antibody technique for visualizing antibody-bacteria complexes in urine. The presence or absence of antibody-coated bacteria in urine correlates with localization of urinary tract infection in the kidney or bladder, respectively.] |